CRISPR Pioneer Launches Startup to Advance Personalized Gene-Editing Therapies
TL;DR Summary
Menlo Ventures has invested $16 million in Aurora Therapeutics, co-founded by CRISPR pioneer Jennifer Doudna and Fyodor Urnov, to develop personalized CRISPR therapies targeting rare diseases like PKU, leveraging recent regulatory and technological advances to make treatments for ultra-rare conditions more feasible.
Topics:business#aurora-therapeutics#crispr#healthcare#menlo-ventures#personalized-medicine#rare-diseases
- Baby KJ scientist launches personalized CRISPR therapy startup Fierce Biotech
- Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines statnews.com
- A new CRISPR startup is betting regulators will ease up on gene-editing MIT Technology Review
- Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies BioPharma Dive
- Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments WIRED
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
87%
318 → 42 words
Want the full story? Read the original article
Read on Fierce Biotech